347 related articles for article (PubMed ID: 21991952)
1. Adverse health outcomes in women exposed in utero to diethylstilbestrol.
Hoover RN; Hyer M; Pfeiffer RM; Adam E; Bond B; Cheville AL; Colton T; Hartge P; Hatch EE; Herbst AL; Karlan BY; Kaufman R; Noller KL; Palmer JR; Robboy SJ; Saal RC; Strohsnitter W; Titus-Ernstoff L; Troisi R
N Engl J Med; 2011 Oct; 365(14):1304-14. PubMed ID: 21991952
[TBL] [Abstract][Full Text] [Related]
2. Continued follow-up of pregnancy outcomes in diethylstilbestrol-exposed offspring.
Kaufman RH; Adam E; Hatch EE; Noller K; Herbst AL; Palmer JR; Hoover RN
Obstet Gynecol; 2000 Oct; 96(4):483-9. PubMed ID: 11004345
[TBL] [Abstract][Full Text] [Related]
3. Six cases of women with diethylstilbestrol in utero demonstrating long-term manifestations and current evaluation guidelines.
Tedeschi CA; Rubin M; Krumholz BA
J Low Genit Tract Dis; 2005 Jan; 9(1):11-8. PubMed ID: 15870516
[TBL] [Abstract][Full Text] [Related]
4. Prenatal diethylstilbestrol exposure and high-grade squamous cell neoplasia of the lower genital tract.
Troisi R; Hatch EE; Palmer JR; Titus L; Robboy SJ; Strohsnitter WC; Herbst AL; Adam E; Hyer M; Hoover RN
Am J Obstet Gynecol; 2016 Sep; 215(3):322.e1-8. PubMed ID: 26979629
[TBL] [Abstract][Full Text] [Related]
5. Risk of breast cancer in women exposed to diethylstilbestrol in utero: prelimiinary results (United States).
Palmer JR; Hatch EE; Rosenberg CL; Hartge P; Kaufman RH; Titus-Ernstoff L; Noller KL; Herbst AL; Rao RS; Troisi R; Colton T; Hoover RN
Cancer Causes Control; 2002 Oct; 13(8):753-8. PubMed ID: 12420954
[TBL] [Abstract][Full Text] [Related]
6. DES daughters in France: experts' points of view on the various genital, uterine and obstetric pathologies, and in utero DES exposure.
Clement R; Guilbaud E; Barrios L; Rougé-Maillart C; Jousset N; Rodat O
Med Sci Law; 2014 Oct; 54(4):219-29. PubMed ID: 24534146
[TBL] [Abstract][Full Text] [Related]
7. Estrogen Metabolism in Postmenopausal Women Exposed
Troisi R; Hatch EE; Palmer JR; Titus L; Sampson JN; Xu X; Hoover RN
Cancer Epidemiol Biomarkers Prev; 2018 Oct; 27(10):1208-1213. PubMed ID: 30049842
[No Abstract] [Full Text] [Related]
8. Diethylstilbestrol: Potential health risks for women exposed in utero and their offspring.
Conlon JL
JAAPA; 2017 Feb; 30(2):49-52. PubMed ID: 28098674
[TBL] [Abstract][Full Text] [Related]
9. The development of cervical and vaginal adenosis as a result of diethylstilbestrol exposure in utero.
Laronda MM; Unno K; Butler LM; Kurita T
Differentiation; 2012 Oct; 84(3):252-60. PubMed ID: 22682699
[TBL] [Abstract][Full Text] [Related]
10. Diethylstilbestrol in pregnancy: an update.
Kinch RA
Can Med Assoc J; 1982 Nov; 127(9):812-3. PubMed ID: 7139494
[TBL] [Abstract][Full Text] [Related]
11. Cancer risk in women exposed to diethylstilbestrol in utero.
Hatch EE; Palmer JR; Titus-Ernstoff L; Noller KL; Kaufman RH; Mittendorf R; Robboy SJ; Hyer M; Cowan CM; Adam E; Colton T; Hartge P; Hoover RN
JAMA; 1998 Aug; 280(7):630-4. PubMed ID: 9718055
[TBL] [Abstract][Full Text] [Related]
12. Incidence of squamous neoplasia of the cervix and vagina in women exposed prenatally to diethylstilbestrol (United States).
Hatch EE; Herbst AL; Hoover RN; Noller KL; Adam E; Kaufman RH; Palmer JR; Titus-Ernstoff L; Hyer M; Hartge P; Robboy SJ
Cancer Causes Control; 2001 Nov; 12(9):837-45. PubMed ID: 11714112
[TBL] [Abstract][Full Text] [Related]
13. Behavior of estrogen-associated female genital tract cancer and its relation to neoplasia following intrauterine exposure to diethylstilbestrol (DES).
Herbst AL
Gynecol Oncol; 2000 Feb; 76(2):147-56. PubMed ID: 10637063
[No Abstract] [Full Text] [Related]
14. Intrauterine exposure to diethylstilbestrol: long-term effects in humans.
Swan SH
APMIS; 2000 Dec; 108(12):793-804. PubMed ID: 11252812
[TBL] [Abstract][Full Text] [Related]
15. Clinical implications of DES.
Kruse K; Lauver D; Hanson K
Nurse Pract; 2003 Jul; 28(7 Pt 1):26-32,35, table of contents; quiz 35-7. PubMed ID: 12861092
[TBL] [Abstract][Full Text] [Related]
16. Diethylstilbestrol exposure in utero: review of literature.
Glaze GM
J Am Osteopath Assoc; 1984 Feb; 83(6):435-8. PubMed ID: 6368486
[TBL] [Abstract][Full Text] [Related]
17. In utero exposure to diethylstilbestrol (DES) does not increase genomic instability in normal or neoplastic breast epithelium.
Larson PS; Ungarelli RA; de Las Morenas A; Cupples LA; Rowlings K; Palmer JR; Rosenberg CL
Cancer; 2006 Nov; 107(9):2122-6. PubMed ID: 16998936
[TBL] [Abstract][Full Text] [Related]
18. Age at natural menopause in women exposed to diethylstilbestrol in utero.
Hatch EE; Troisi R; Wise LA; Hyer M; Palmer JR; Titus-Ernstoff L; Strohsnitter W; Kaufman R; Adam E; Noller KL; Herbst AL; Robboy S; Hartge P; Hoover RN
Am J Epidemiol; 2006 Oct; 164(7):682-8. PubMed ID: 16887893
[TBL] [Abstract][Full Text] [Related]
19. Dysplasia and cytologic findings in 4,589 young women enrolled in diethylstilbestrol-adenosis (DESAD) project.
Robboy SJ; Szyfelbein WM; Goellner JR; Kaufman RH; Taft PD; Richard RM; Gaffey TA; Prat J; Virata R; Hatab PA; McGorray SP; Noller KL; Townsend D; Labarthe D; Barnes AB
Am J Obstet Gynecol; 1981 Jul; 140(5):579-86. PubMed ID: 7195652
[TBL] [Abstract][Full Text] [Related]
20. Diethylstilbestrol (DES): also harms the third generation.
Prescrire Int; 2016 Dec; 25(177):294-298. PubMed ID: 30758926
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
